Sarcoma News

Just as physicians became accustomed to wearing pagers 40 years ago or being tied to smartphones 2 decades ago, many have become active on social media as it entered their practices.

An important component of cancer care is communication with patients and caregivers about their disease.

Most cancer drug approvals between 2016 and 2021 applied to second-, third- or later-line treatment settings and did not displace current standard-of-care therapies, according to a study published in JAMA Network Open.

James Amatruda, MD, PhD, never set out to become a fish farmer.

Rare Disease Day is Feb. 28.

Fox Chase Cancer Center announced two faculty appointments.

The FDA cleared investigational new drug applications for three cell therapies in development for oncology indications.

TAMPA, Fla. — In a video at the Orthopaedic Research Society Annual Meeting, Emily E. Seiden, BS, discusses romidepsin, which showed promise as a therapeutic to target micrometastases progression in osteosarcoma.

President Joe Biden has unfinished business with cancer.

Ripretinib did not extend PFS compared with sunitinib for patients with advanced gastrointestinal stromal tumor who previously received imatinib, according to randomized phase 3 study results presented during the ASCO Plenary Series.